Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 743634, 10 pages
http://dx.doi.org/10.1155/2014/743634
Research Article

Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors

1Department of Biomedicine and Prevention, Division of Clinical Nutrition and Nutrigenomics, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
2Nuova Clinica Annunziatella, 00147 Roma, Italy
3Department of Surgery and Medical Science, University “Magna Graecia”, 88100 Germaneto, Italy
4Department of Agriculture, University of Naples “Federico II”, 80055 Portici, Italy
5Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
6CNR, ISN UOS of Pharmacology, Department of Pharmacology, University “Magna Graecia”, 88100 Roccelletta di Borgia, Italy
7National Institute for Mediterranean Diet and Nutrigenomics (I.N.Di.M.), 87032 Amantea, Italy

Received 24 July 2014; Accepted 22 September 2014; Published 13 October 2014

Academic Editor: Stamatios Theocharis

Copyright © 2014 Laura Di Renzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Mensah, A. H. Mokdad, E. Ford et al., “Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications,” Cardiology Clinics, vol. 22, no. 4, pp. 485–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Shuldiner, “Obesity genes and gene-environment-behavior interactions: recommendations for a way forward,” Obesity, vol. 16, supplement 3, pp. S79–S81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. Tian, N. D. Price, and L. Hood, “Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine,” Journal of Internal Medicine, vol. 271, no. 2, pp. 111–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. L. Jenkins and A. Maayan, “Systems pharmacology meets predictive, preventive, personalized and participatory medicine,” Pharmacogenomics, vol. 14, no. 2, pp. 119–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Reiling, V. Lyssenko, J. M. A. Boer et al., “Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time,” European Journal of Human Genetics, vol. 20, no. 6, pp. 696–700, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. I. Leu, M. E. Murphy, and D. L. George, “The p53 codon 72 polymorphism modifies the cellular response to inflammatory challenge in the liver,” Journal of Liver, vol. 2, no. 1, 2013. View at Google Scholar
  7. O. Couture, E. Lombardi, K. Davis, E. Hays, and N. Chandar, “Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation,” PLoS ONE, vol. 8, no. 11, Article ID e82494, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Lynch, Z. H. Shah, S. J. Allison et al., “SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53,” PLoS ONE, vol. 5, no. 10, Article ID e13502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-S. Jeong, W. Hu, V. Belyi, R. Rabadan, and A. J. Levine, “Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: P53 with arginine at codon 72 favors apoptosis,” The FASEB Journal, vol. 24, no. 5, pp. 1347–1353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schwarzkopf, D. Coletti, G. Marazzi, and D. Sassoon, “p53 activity induces muscle atrophy and stem cell perturbation,” Basic Applied Myology, vol. 18, no. 5, pp. 131–138, 2008. View at Google Scholar
  11. A. Porrello, M. A. Cerone, S. Coen et al., “p53 regulates myogenesis by triggering the differentiation activity of pRb,” Journal of Cell Biology, vol. 151, no. 6, pp. 1295–1303, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. V. D. O. N. Teixeira, L. I. Filippin, and R. M. Xavier, “Mechanisms of muscle wasting in sarcopenia,” Revista Drasileira de Reumatologia, vol. 52, no. 2, pp. 252–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Vogelstein, D. Lane, and A. J. Levine, “Surfing the p53 network,” Nature, vol. 408, no. 6810, pp. 307–310, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. W. J. Evans, “Skeletal muscle loss: cachexia, sarcopenia, and inactivity,” The American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1123S–1127S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Cruz-Jentoft, J. P. Baeyens, J. M. Bauer et al., “Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People,” Age and Ageing, vol. 39, no. 4, pp. 412–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Fanzani, V. M. Conraads, F. Penna, and W. Martinet, “Molecular and cellular mechanisms of skeletal muscle atrophy: an update,” Journal of Cachexia, Sarcopenia and Muscle, vol. 3, no. 3, pp. 163–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-Y. Chung, H.-T. Kang, D.-C. Lee, H.-R. Lee, and Y.-J. Lee, “Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity,” Archives of Gerontology and Geriatrics, vol. 56, no. 1, pp. 270–278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. O. Silva, M. G. O. Karnikowski, S. S. Funghetto et al., “Association of body composition with sarcopenic obesity in elderly women,” International Journal of General Medicine, vol. 6, pp. 25–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Coin, S. Sarti, E. Ruggiero et al., “Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an italian population aged 20 to 80,” Journal of the American Medical Directors Association, vol. 14, no. 7, pp. 507–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. de Lorenzo, R. Martinoli, F. Vaia, and L. di Renzo, “Normal weight obese (NWO) women: an evaluation of a candidate new syndrome,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 8, pp. 513–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. de Lorenzo, V. del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. di Renzo, “Normal-weight obese syndrome: early inflammation?” The American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 40–45, 2007. View at Google Scholar · View at Scopus
  22. L. di Renzo, V. del Gobbo, M. Bigioni, M. G. Premrov, R. Cianci, and A. De Lorenzo, “Body composition analyses in normal weight obese women,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 4, pp. 191–196, 2006. View at Google Scholar · View at Scopus
  23. World Health Organization, Obesity: Preventing and Managing the Global Epidemic.Report Series 894 on a WHO Consultation on Obesity, World Health Organization, Geneva, Swizerland, 2000.
  24. A. De Lorenzo, A. Bianchi, P. Maroni et al., “Adiposity rather than BMI determines metabolic risk,” International Journal of Cardiology, vol. 166, no. 1, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, J. C. Thornton, S. Bari et al., “Comparisons of waist circumferences measured at 4 sites,” The American Journal of Clinical Nutrition, vol. 77, no. 2, pp. 379–384, 2003. View at Google Scholar · View at Scopus
  26. O. De la Calle-Martin, V. Fabregat, M. Romero, J. Soler, J. Vives, and J. Yague, “AccII polymorphism of the p53 gene,” Nucleic Acids Research, vol. 18, no. 16, p. 4963, 1990. View at Google Scholar · View at Scopus
  27. P. Bruzzi, S. B. Green, D. Byar, L. A. Brinton, and C. Schairer, “Estimating the population attributable risk for multiple risk factors using case-control data,” American Journal of Epidemiology, vol. 122, no. 5, pp. 904–914, 1985. View at Google Scholar · View at Scopus
  28. C. J. Henley-Smith, F. E. Steffens, F. S. Botha, and N. Lall, “Predicting the influence of multiple components on microbial inhibition using a logistic response model—a novel approach,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 190, 2014. View at Google Scholar
  29. R. R. Hocking, “The analysis and selection of variables in linear regression,” Biometrics, vol. 32, no. 1, pp. 1–49, 1976. View at Google Scholar · View at MathSciNet · View at Scopus
  30. R. L. Marcus, O. Addison, L. E. Dibble, K. B. Foreman, G. Morrell, and P. Lastayo, “Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals,” Journal of Aging Research, vol. 2012, Article ID 629637, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Conte, F. Vasuri, G. Trisolino et al., “Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness,” PLoS ONE, vol. 8, no. 8, Article ID e73709, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. D. Molkentin and E. N. Olson, “Defining the regulatory networks for muscle development,” Current Opinion in Genetics & Development, vol. 6, no. 4, pp. 445–453, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Parker, G. Eichele, P. Zhang et al., “p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells,” Science, vol. 267, no. 5200, pp. 1024–1027, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. K. H. Vousden and D. P. Lane, “p53 in health and disease,” Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 275–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. D. Tyner, S. Venkatachalam, J. Choi et al., “p53 mutant mice that display early ageing-associated phenotypes,” Nature, vol. 415, no. 6867, pp. 45–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Mazzaro, G. Bossi, S. Coen, A. Sacchi, and S. Soddu, “The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells,” Oncogene, vol. 18, no. 42, pp. 5831–5835, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Machida and F. W. Booth, “Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals,” Experimental Gerontology, vol. 39, no. 10, pp. 1521–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Su, Y. Mei, and S. Sinha, “Role of the crosstalk between autophagy and apoptosis in cancer,” Journal of Oncology, vol. 2013, Article ID 102735, 14 pages, 2013. View at Publisher · View at Google Scholar
  39. C. Rommel, S. C. Bodine, B. A. Clarke et al., “Mediation of IGF-1-induced skeletal myotube hypertrophy by Pl(3)K/Alt/mTOR and Pl(3)K/Akt/GSK3 pathways,” Nature Cell Biology, vol. 3, no. 11, pp. 1009–1013, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. S. C. Kandarian and R. W. Jackman, “Intracellular signaling during skeletal muscle atrophy,” Muscle and Nerve, vol. 33, no. 2, pp. 155–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Yaron, A. Hatzubai, M. Davis et al., “Identification of the receptor component of the IκBα-ubiquitin ligase,” Nature, vol. 396, no. 6711, pp. 590–594, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Romero-Corral, V. K. Somers, J. Sierra-Johnson et al., “Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality,” European Heart Journal, vol. 31, no. 6, pp. 737–746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Marques-Vidal, A. Pécoud, D. Hayoz et al., “Prevalence of normal weight obesity in Switzerland: effect of various definitions,” European Journal of Nutrition, vol. 47, no. 5, pp. 251–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. L. di Renzo, M. Bigioni, F. G. Bottini et al., “Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-15R-alpha and MTHFR 677CT genes in the relationship between body composition and resting metabolic rate,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 5, pp. 235–245, 2006. View at Google Scholar
  45. L. Di Renzo, M. Bigioni, V. del Gobbo et al., “Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 α and β plasma levels,” Pharmacological Research, vol. 55, no. 2, pp. 131–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. di Renzo, A. Bertoli, M. Bigioni et al., “Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome,” Current Pharmaceutical Design, vol. 14, no. 26, pp. 2699–2706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Di Renzo, F. Galvano, C. Orlandi et al., “Oxidative stress in normal-weight obese syndrome,” Obesity, vol. 18, no. 11, pp. 2125–2130, 2010. View at Google Scholar
  48. S. Kang, C. Kyung, J. S. Park et al., “Subclinical vascular inflammation in subjects with normal weight obesity and its association with body Fat: an 18 F-FDG-PET/CT study,” Cardiovascular Diabetology, vol. 13, no. 1, article 70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. F. B. Madeira, A. A. Silva, H. F. Veloso et al., “Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country,” PLoS ONE, vol. 8, no. 3, Article ID e60673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Oliveros, V. K. Somers, O. Sochor, K. Goel, and F. Lopez-Jimenez, “The concept of normal weight obesity,” Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 426–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Kim, Z. Wang, S. B. Heymsfield, R. N. Baumgartner, and D. Gallagher, “Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method,” The American Journal of Clinical Nutrition, vol. 76, no. 2, pp. 378–383, 2002. View at Google Scholar · View at Scopus
  52. I. Janssen, P. T. Katzmarzyk, and R. Ross, “Waist circumference and not body mass index explains obesity-related health risk,” The American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 379–384, 2004. View at Google Scholar · View at Scopus
  53. Y. D. Tchoukalova, S. B. Votruba, T. Tchkonia, N. Giorgadze, J. L. Kirkland, and M. D. Jensen, “Regional differences in cellular mechanisms of adipose tissue gain with overfeeding,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 42, pp. 18226–18231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. D. Tchoukalova, C. Koutsari, M. V. Karpyak, S. B. Votruba, E. Wendland, and M. D. Jensen, “Subcutaneous adipocyte size and body fat distribution,” The American Journal of Clinical Nutrition, vol. 87, no. 1, pp. 56–63, 2008. View at Google Scholar · View at Scopus
  55. R. Roubenoff, “Catabolism of aging: is it an inflammatory process?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, no. 3, pp. 295–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Shapira, “Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine,” The EPMA Journal, vol. 4, no. 1, p. 1, 2013. View at Publisher · View at Google Scholar
  57. A. De Lorenzo, A. Nardi, L. Iacopino et al., “A for evaluating women body fat percentage and obesity-related cardiovascular disease risk,” Journal of Endocrinological Investigation, vol. 37, no. 6, pp. 511–524, 2014. View at Publisher · View at Google Scholar
  58. L. Hood, J. R. Heath, M. E. Phelps, and B. Lin, “Systems biology and new technologies enable predictive and preventative medicine,” Science, vol. 306, no. 5696, pp. 640–643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. G. W. Carter, D. J. Galas, and T. Galitski, “Maximal extraction of biological information from genetic interaction data,” PLoS Computational Biology, vol. 5, no. 4, Article ID e1000347, 2009. View at Publisher · View at Google Scholar · View at Scopus